Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - OTHER LIABILITIES
Other Liabilities ALNY - Alnylam Pharmaceuticals, Inc.
308 M
LAST VALUE
76.54%
2 YEAR CAGR
37.44%
5 YEAR CAGR
59.33%
10 YEAR CAGR